BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will participate in two investor conferences during March:
- 34th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton, Laguna Niguel, CA. Management will participate in a “Fireside Chat” on Monday, March 14th at 2:00 p.m. PT and will be available for one-on-one meetings throughout the conference.
- Oppenheimer’s 32nd Annual Healthcare Conference, March 15-16, 2022. Management will deliver a company presentation on Wednesday, March 16th at 2:00 p.m. ET and will be available for one-on-one virtual meetings. A live webcast of the presentation will be available here and will also be archived in the Investors section of the Company’s website.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.